Guardant Health: A Promising Player in the Liquid Biopsy Market

From Nasdaq: 2025-05-16 19:30:00

In this Motley Fool Scoreboard episode, experts analyze Guardant Health (NASDAQ: GH) for potential investment opportunities. The video was published on May 16, 2025, using stock prices from April 9, 2025. Notably, Guardant Health did not make it to the list of the 10 best stocks to buy right now, according to the Motley Fool Stock Advisor analyst team. However, the team’s recommendations have historically outperformed the market, with a total average return of 967%, compared to the S&P 500’s 171%. Consider joining Stock Advisor to access the latest top 10 list of stocks.



Read more at Nasdaq: Guardant Health: A Promising Player in the Liquid Biopsy Market